Skip to main content
Clinical Trials/NCT03631628
NCT03631628
Recruiting
Not Applicable

A Randomized Controlled Clinical Trial of Upper Limb Training with Mirror Therapy (MT) and Bilateral Transcutaneous Electrical Nerve Stimulation (Bi-TENS) to Improve Upper Limb Motor Functions in Patients with Stroke

The Hong Kong Polytechnic University2 sites in 1 country90 target enrollmentJanuary 1, 2021
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
The Hong Kong Polytechnic University
Enrollment
90
Locations
2
Primary Endpoint
Fugl-Meyer Assessment of Upper Extremity (FMA-UE) - post-training
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This study compare the effectiveness of 2 rehabilitation programmes that use (1) MT with Bilateral TENS (Bi-TENS), (2) sham-MT with Bi-TENS (Bi-TENS), respectively, in addition to conventional rehabilitation of standardized upper limb training, in improving upper limb motor functions, activities of daily living, community integration, and quality of life in patients with stroke.

Detailed Description

The principal aim of the proposed study will be to demonstrate whether MT with Bi-TENS is more effective than sham-MT with Bi-TENS in improving upper limb motor functions, activities of daily living, community integration and quality of life in patients with stroke. The null hypothesis will be that MT with Bi-TENS is not significantly different from sham-MT with Bi-TENS in improving upper limb motor functions, activities of daily living, community integration, and quality of life in patients with stroke.

Registry
clinicaltrials.gov
Start Date
January 1, 2021
End Date
December 31, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Shamay Ng

Professor

The Hong Kong Polytechnic University

Eligibility Criteria

Inclusion Criteria

  • have been diagnosed with ischemic brain injury or intracerebral hemorrhage by MRI or computed tomography within three weeks to 10 years after the first onset of stroke;
  • have volitional control of the non-paretic arm, and at least minimal antigravity movement in the shoulder of the paretic arm;
  • have at least 5 degrees in wrist extension of the paretic arm in the antigravity position
  • are able to score \> 6 of 10 of abbreviated Mental Test;
  • are able to follow instruction and give informed consent of the study.

Exclusion Criteria

  • Have any additional medical, cardiovascular and orthopedic condition that would hinder the proper assessment and treatment;
  • Use cardiac pacemakers;
  • Have receptive dysphasia;
  • Have a significant upper limb peripheral neuropathy (e.g., diabetic polyneuropathy);
  • Have severe shoulder, elbow, wrist or finger contractures that would preclude a passive range of motions of the arm;
  • Have skin allergy that would prevent electrical stimulation;
  • Are involved in drug studies or other clinical trials.

Outcomes

Primary Outcomes

Fugl-Meyer Assessment of Upper Extremity (FMA-UE) - post-training

Time Frame: 8 weeks

The FMA-UE will be used to evaluate the severity of motor impairment in the paretic upper extremity. The performance of 33 tasks will be assessed using a three-point ordinal scale (0 to 2), with a maximum score of 66. The FMA-UE will assess voluntary movement, reflex activity, grasp, and coordination of the upper extremity, and has a high inter-rater reliability (r=0.99) in patients with stroke. A higher scale score indicates a less severe motor impairment.

Fugl-Meyer Assessment of Upper Extremity (FMA-UE) - followup

Time Frame: 12 weeks

The FMA-UE will be used to evaluate the severity of motor impairment in the paretic upper extremity. The performance of 33 tasks will be assessed using a three-point ordinal scale (0 to 2), with a maximum score of 66. The FMA-UE will assess voluntary movement, reflex activity, grasp, and coordination of the upper extremity, and has a high inter-rater reliability (r=0.99) in patients with stroke. A higher scale score indicates a less severe motor impairment.

Wolf Motor Function Test (WMFT) - midterm

Time Frame: 4 weeks

Upper limb function will be assessed by the WMFT, which comprises two items of strength-based tasks, and 15 items of function-based tasks. The two strength-based tasks will be measured by weight lift and grip strength. The 15 function-based tasks will be assessed by the time taken to complete each task (in seconds), and the quality rating of the use of the paretic hand in attempting each task (graded 0 to 5). The scores for the 15 tasks will be summed and then averaged to yield the mean functional ability score. The WMFT has a high inter-rater reliability (ICC=0.97) and test-retest reliability for time scores (ICC=0.95). A higher score indicates a better hand function.

Wolf Motor Function Test (WMFT) - baseline

Time Frame: Baseline (0 week)

Upper limb function will be assessed by the WMFT, which comprises two items of strength-based tasks, and 15 items of function-based tasks. The two strength-based tasks will be measured by weight lift and grip strength. The 15 function-based tasks will be assessed by the time taken to complete each task (in seconds), and the quality rating of the use of the paretic hand in attempting each task (graded 0 to 5). The scores for the 15 tasks will be summed and then averaged to yield the mean functional ability score. The WMFT has a high inter-rater reliability (ICC=0.97) and test-retest reliability for time scores (ICC=0.95). A higher score indicates a better hand function.

Fugl-Meyer Assessment of Upper Extremity (FMA-UE) - baseline

Time Frame: Baseline (0 week)

The FMA-UE will be used to evaluate the severity of motor impairment in the paretic upper extremity. The performance of 33 tasks will be assessed using a three-point ordinal scale (0 to 2), with a maximum score of 66. The FMA-UE will assess voluntary movement, reflex activity, grasp, and coordination of the upper extremity, and has a high inter-rater reliability (r=0.99) in patients with stroke. A higher scale score indicates a less severe motor impairment.

Fugl-Meyer Assessment of Upper Extremity (FMA-UE) - midterm

Time Frame: 4 weeks

The FMA-UE will be used to evaluate the severity of motor impairment in the paretic upper extremity. The performance of 33 tasks will be assessed using a three-point ordinal scale (0 to 2), with a maximum score of 66. The FMA-UE will assess voluntary movement, reflex activity, grasp, and coordination of the upper extremity, and has a high inter-rater reliability (r=0.99) in patients with stroke. A higher scale score indicates a less severe motor impairment.

Wolf Motor Function Test (WMFT) - post-training

Time Frame: 8 weeks

Upper limb function will be assessed by the WMFT, which comprises two items of strength-based tasks, and 15 items of function-based tasks. The two strength-based tasks will be measured by weight lift and grip strength. The 15 function-based tasks will be assessed by the time taken to complete each task (in seconds), and the quality rating of the use of the paretic hand in attempting each task (graded 0 to 5). The scores for the 15 tasks will be summed and then averaged to yield the mean functional ability score. The WMFT has a high inter-rater reliability (ICC=0.97) and test-retest reliability for time scores (ICC=0.95). A higher score indicates a better hand function.

Wolf Motor Function Test (WMFT) - followup

Time Frame: 12 weeks

Upper limb function will be assessed by the WMFT, which comprises two items of strength-based tasks, and 15 items of function-based tasks. The two strength-based tasks will be measured by weight lift and grip strength. The 15 function-based tasks will be assessed by the time taken to complete each task (in seconds), and the quality rating of the use of the paretic hand in attempting each task (graded 0 to 5). The scores for the 15 tasks will be summed and then averaged to yield the mean functional ability score. The WMFT has a high inter-rater reliability (ICC=0.97) and test-retest reliability for time scores (ICC=0.95). A higher score indicates a better hand function.

Secondary Outcomes

  • Grip Strength - baseline(Baseline (0 week))
  • Grip Strength - post-training(8 weeks)
  • Grip Strength - followup(12 weeks)
  • Jacket Test - baseline(Baseline (0 week))
  • Jacket Test - post-training(8 weeks)
  • Motor Activity Log (MAL) - baseline(Baseline (0 week))
  • Motor Activity Log (MAL) - midterm(4 weeks)
  • Stroke Impact Scale (SIS) - baseline(Baseline (0 week))
  • Stroke Impact Scale (SIS) - followup(12 weeks)
  • Community Integration Questionnaire (CIM) - post-training(8 weeks)
  • SATIS-Stroke - midterm(4 weeks)
  • Grip Strength - midterm(4 weeks)
  • Upper Extremity Functional Index (UEFI) - midterm(4 weeks)
  • Upper Extremity Functional Index (UEFI) - followup(12 weeks)
  • Stroke Impact Scale (SIS) - midterm(4 weeks)
  • SATIS-Stroke- post-training(8 weeks)
  • Jacket Test - midterm(4 weeks)
  • Jacket Test - followup(12 weeks)
  • Motor Activity Log (MAL) - post-training(8 weeks)
  • - Motor Activity Log (MAL) - followup(12 weeks)
  • Stroke Impact Scale (SIS) - post-training(8 weeks)
  • Community Integration Questionnaire (CIM) - baseline(Baseline (0 week))
  • Community Integration Questionnaire (CIM) - midterm(4 weeks)
  • SATIS-Stroke - baseline(Baseline (0 week))
  • Upper Extremity Functional Index (UEFI) - baseline(Baseline (0 week))
  • Upper Extremity Functional Index (UEFI) - post-training(8 weeks)
  • Community Integration Questionnaire (CIM) - followup(12 weeks)
  • SATIS-Stroke - followup(12 weeks)

Study Sites (2)

Loading locations...

Similar Trials